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The purpose of this paper is to present a general view of the current applications of fuzzy logic in medicine and bioinformatics.
We particularly review the medical literature using fuzzy logic. We then recall the geometrical interpretation of fuzzy sets as points
in a fuzzy hypercube and present two concrete illustrations in medicine (drug addictions) and in bioinformatics (comparison of
genomes).
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INTRODUCTION
The diagnosis of disease involves several levels of uncertainty
and imprecision, and it is inherent to medicine.
A single disease may manifest itself quite diﬀerently, de-
pending on the patient, and with diﬀerent intensities. A sin-
gle symptom may correspond to diﬀerent diseases. On the
other hand, several diseases present in a patient may interact
andinterferewiththeusualdescriptionofanyofthediseases.
The best and most precise description of disease entities
useslinguistictermsthatarealsoimpreciseandvague.More-
over, the classical concepts of health and disease are mutually
exclusive and opposite. However, some recent approaches
consider both concepts as complementary processes in the
same continuum [1–6]. According to the deﬁnition issued
by the World Health Organization (WHO), health is as t a t e
of complete physical, mental, and social well-being, and not
m e r e l yt h ea b s e n c eo fd i s e a s eo ri n ﬁ r m i t y . The loss of health
can be seen in its three forms: disease, illness, and sickness.
To deal with imprecision and uncertainty, we have at our
disposal fuzzy logic. Fuzzy logic introduces partial truth val-
ues, between true and false.
AccordingtoAristotelianlogic,foragivenpropositionor
state we only have two logical values: true-false, black-white,
1-0. In real life, things are not either black or white, but most
of the times are grey. Thus, in many practical situations, it
is convenient to consider intermediate logical values. Let us
show this with a very simple medical example. Consider the
statement “you are healthy.” Is it true if you have only a bro-
ken nail? Is it false if you have a terminal cancer? Everybody
is healthy to some degree h and ill to some degree i.I fy o ua r e
totally healthy, then of course h = 1, i = 0. Usually, every-
body has some minor health problems and h<1, but
h+i = 1. (1)
In the other extreme situation, h = 0, and i = 1 so that you
are not healthy at all (you are dead). In the case you have
only a broken nail, we may write h = 0.999, i = 0.001; if you
have a painful gastric ulcer, i = 0.6, h = 0.4, but in the case
y o uh a v eat e r m i n a lc a n c e r ,p r o b a b l yi = 0.95, h = 0.05. As
we will see, this is a particular case of Kosko’s hypercube: the
one-dimensional case [4].
Uncertainty is now considered essential to science and
fuzzy logic is a way to model and deal with it using natural
language. We can say that fuzzy logic is a qualitative compu-
tational approach.
Since uncertainty is inherent in ﬁelds such as medicine
and massive data in bioinformatics, and fuzzy logic takes
into account such uncertainty, fuzzy set theory can be con-
sidered as a suitable formalism to deal with the imprecision
intrinsic to many biomedical and bioinformatics problems.
Fuzzy logic is a method to render precise what is imprecise in
the world of medicine. Several examples and illustrations are
mentioned below.
FUZZY LOGIC IN MEDICINE
Thecomplexityofmedicalpracticemakestraditionalquanti-
tative approaches of analysis inappropriate. In medicine, the
lack of information, and its imprecision, and, many times,2 Journal of Biomedicine and Biotechnology
contradictory nature are common facts. The sources of un-
certainty can be classiﬁed as follows [7].
(1) Information about the patient.
(2) Medical history of the patient, which is usually sup-
plied by the patient and/or his/her family. This is usu-
ally highly subjective and imprecise.
(3) Physical examination. The physician usually obtains
objective data, but in some cases the boundary be-
tween normal and pathological status is not sharp.
(4) Results of laboratory and other diagnostic tests, but
they are also subject to some mistakes, and even to im-
proper behavior of the patient prior to the examina-
tion.
(5) The patient may include simulated, exaggerated, un-
derstatedsymptoms,ormayevenfailtomentionsome
of them.
(6) We stress the paradox of the growing number of men-
tal disorders versus the absence of a natural classiﬁca-
tion [8]. The classiﬁcation in critical (ie, borderline)
casesisdiﬃcult,particularlywhenacategoricalsystem
of diagnosis is considered.
Fuzzy logic plays an important role in medicine [7, 9–
14]. Some examples showing that fuzzy logic crosses many
disease groups are the following.
(1) To predict the response to treatment with citalopram
in alcohol dependence [15].
(2) Toanalyzediabeticneuropathy[16]andt odet ectearly
diabetic retinopathy [17].
(3) To determine appropriate lithium dosage [18, 19].
(4) Tocalculatevolumesofbraintissuefrommagneticres-
onance imaging (MRI) [20], and to analyze functional
MRI data [21].
(5) To characterize stroke subtypes and coexisting causes
of ischemic stroke [1, 3, 22, 23].
(6) Toimprovedecision-makinginradiationtherapy[24].
(7) To control hypertension during anesthesia [25].
(8) To determine ﬂexor-tendon repair techniques [26].
(9) To detect breast cancer [27, 28], lung cancer [28], or
prostate cancer [29].
(10) To assist the diagnosis of central nervous systems tu-
mors (astrocytic tumors) [30].
(11) To discriminate benign skin lesions from malignant
melanomas [31].
(12) To visualize nerve ﬁbers in the human brain [32].
(13) To represent quantitative estimates of drug use [33].
(14) TostudytheauditoryP50componentinschizophrenia
[34].
(15) Many other areas of application, to mention a few, are
(a) to study fuzzy epidemics [35],
(b) to make decisions in nursing [36],
(c) to overcome electroacupuncture accommoda-
tion [37].
We used the database MEDLINE to identify the medical
publications using fuzzy logic. We used as keywords fuzzy
logic and grade of membership. The total number of articles
peryearappearsinTable 1.Thedataisfrom1991to2002and
Table 1: Number of papers per year in medicine using fuzzy logic.
Year Number
≤ 1990 13
1991 2
1992 14
1993 24
1994 38
1995 66
1996 58
1997 76
1998 66
1999 68
2000 76
2001 128
2002 175
includes also the number of those publications in 1990 and
before. It results in a total of 804 articles and agrees essen-
tiallywiththenumbersindicatedin[7,13].Weplantoscreen
databases in the engineering literature that covers medicine-
related articles since it is diﬃcult to publish medical results
using a fuzzy logic approach. In the future we will compare
the ﬁgures obtained.
Figure 1 indicates an exponential growth in the number
of articles in medicine making use of fuzzy technology. The
preliminary data we have for 2003 and 2004 [38]s u p p o r t s
this tendency.
FUZZY LOGIC IN BIOINFORMATICS
Bioinformatics derives knowledge from computer analysis
of biological data. This data can consist of the information
stored in the genetic code, and also experimental results (and
hence imprecision) from various sources, patient statistics,
and scientiﬁc literature. Bioinformatics combines computer
science, biology, physical and chemical principles, and tools
for analysis and modeling of large sets of biological data, the
managing of chronic diseases, the study of molecular com-
puting, cloning, and the development of training tools of
bio-computing systems [39]. Bioinformatics is a very active
and attractive research ﬁeld with a high impact in new tech-
nological development [40].
Molecular biologists are currently engaged in some of
themostimpressivedatacollectionprojects.Recentgenome-
sequencing projects are generating an enormous amount
of data related to the function and the structure of bi-
ological molecules and sequences. Other complementary
high-throughput technologies, such as DNA microarrays,
are rapidly generating large amounts of data that are too
overwhelming for conventional approaches to biological
data analysis. We have at our disposal a large number of
genomes, protein structures, genes with their corresponding
expressionsmonitoredinexperiments,andsingle-nucleotide
polymorphisms (SNPs) [41]. For example, the EMBL Nu-
cleotide Sequence Database (http://www.ebi.ac.uk/embl)h a sA .T o r r e sa n dJ .J .N i e t o 3
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Figure 1: Number of publications per year indexed in MEDLINE using fuzzy logic.
increased in 12 months from 18.3 million entries comprising
23Gb (Release 71, September 2002) to 27.2 million entries
comprising over 33Gb (Release 76, September 2003) as indi-
cated in [42].
Handling this massive amount of data, in many cases im-
precise and fuzzy, requires powerful integrated bioinformat-
ics systems and new technologies.
Fuzzylogicandfuzzytechnologyarenowfrequentlyused
in bioinformatics. The following are some examples.
(1) To increase the ﬂexibility of protein motifs [43].
(2) To study diﬀerences between polynucleotides [44].
(3) To analyze experimental expression data [45] using
fuzzy adaptive resonance theory.
(4) Toalignsequencesbasedonafuzzyrecastofadynamic
programming algorithm [46].
(5) DNA sequencing using genetic fuzzy systems [47].
(6) To cluster genes from microarray data [48].
(7) To predict proteins subcellular locations from their
dipeptide composition [49] using fuzzy k-nearest
neighbors algorithm.
(8) To simulate complex traits inﬂuenced by genes with
fuzzy-valued eﬀects in pedigreed populations [50].
( 9 )T oa t t r i b u t ec l u s t e rm e m b e r s h i pv a l u e st og e n e s[ 51]
applying a fuzzy partitioning method, fuzzy C-means.
(10) To map speciﬁc sequence patterns to putative func-
tional classes since evolutionary comparison leads to
eﬃcient functional characterization of hypothetical
proteins [52]. The authors used a fuzzy alignment
model.
(11) To analyze gene expression data [53].
(12) To unravel functional and ancestral relationships be-
tween proteins via fuzzy alignment methods [54], or
using a generalized radial basis function neural net-
work architecture that generates fuzzy classiﬁcation
rules [55].
(13) To analyze the relationships between genes and deci-
pher a genetic network [56].
(14) To process complementary deoxyribonucleic acid
(cDNA) microarray images [57]. The procedure
should be automated due to the large number of spots
and it is achieved using a fuzzy vector ﬁltering frame-
work.
(15) To classify amino acid sequences into diﬀerent super-
families [58].
THE FUZZY HYPERCUBE
In 1992, Kosko [4] introduced a geometrical interpretation
of fuzzy sets as points in a hypercube. In 1998, Helgason and
Jobe [1] used the unit hypercube to represent concomitant
mechanisms in stroke. Indeed, for a given set
X =

x1,...,xn

,( 2 )
a fuzzy subset is just a mapping
μ : X −→ I = [0,1], (3)
and the value μ(x) expresses the grade of membership of the
element x ∈ X to the fuzzy subset μ.
For example, let X be the set of persons of some popu-
lation and let the fuzzy set μ be deﬁned as healthy subjects.
If John is a member of the population (the set X), then, μ
(John) gives the grade of healthiness of John, or the grade
of membership of John to the set of healthy subjects.I fλ is
the fuzzy set that describes the grade of depression, then λ
(Mary) is the degree of depression of Mary.
Thus, the set of all fuzzy subsets (of X) is precisely the
unit hypercube In = [0,1]n, as any fuzzy subset μ determines
a point P ∈ In given by P = (μ(x1),...,μ(xn)). Reciprocally,
any point A = (a1,...,an) ∈ In generates a fuzzy subset μ
deﬁned by μ(xi) = ai, i = 1,...,n. Nonfuzzy or crisp subsets
of X are given by mappings μ : X →{ 0,1}, and are located at
the 2n corners of the n-dimensional unit hypercube In.F o r
graphic representations of the two-dimensional and three-
dimensional hypercube, we refer to [59].
Given,
p =

p1, p2,..., pn

, q =

q1,q2,...,qn

∈ In,( 4 )
n o tb o t he q u a lt ot h ee m p t ys e t∅=(0,0,...,0),wedeﬁne
the diﬀerence between p and q as
d(p,q) =
n
i=1
 pi − qi
 
n
i=1max

pi,qi
. (5)4 Journal of Biomedicine and Biotechnology
0.9 0.8 0.6 0.5 0.4 0.2
Smoking
0.1
0.2
0.4
0.5
0.6
0.8
A
l
c
o
h
o
l
i
s
m
1s u b j e c t
1s u b j e c t
1s u b j e c t
2s u b j e c t s
2s u b j e c t s
7s u b j e c t s
23 subjects
37 subjects
84 subjects
1278 subjects
(0,1)
(0,0) (1,0)
(1,1)
Figure 2: Number of subjects in the two-dimensional fuzzy hyper-
cube I2.
Of course d(∅,∅) = 0. We know that d is indeed a met-
ric [60]. Hypercubical calculus has been described in [61],
while some biomedical applications of the fuzzy unit hyper-
cube are given in [1, 6, 59]. Recently, the fuzzy hypercube has
been utilized to study diﬀerences between polynucleotides
[59]a n dt oc o m p a r eg e n o m e s[ 44, 62].
AN APPLICATION TO DRUG ADDICTIONS
Wenowpresentanexampleoftheuseofthefuzzyhypercube
in a medical case of consumption of drugs.
Consider the following fuzzy variables: smoking and al-
cohol drinking. If you do not smoke, then your degree of be-
ing a smoker is evidently 0. If you smoke, for example, six
cigarettes per day, we say that your degree of being a smoker
is 0.8. If the consumption is ten or more, the degree is 1. See
[63, Figure 3.8] for a geometrical representation of the fuzzy
concept of being a smoker.
With respect to the other fuzzy variable, if you drink no
alcohol, the degree of this variable is 0. If you drink more
than 75cc of alcohol per day, the degree of alcoholism is 1.
For 25cc/d, the degree could be 0.4 and for 50cc/d, 0.8.
Thus, the fuzzy set μ = (0,0) corresponds to a nonsmok-
er and teetotaler. Some further examples are the following:
the set μ = (1,0) represents a heavy smoker, but a teetotaler,
and the set μ = (0.8,1) is a person who smokes about six
cigarettes a day and is a risk consumer of alcohol.
Suppose you correspond to the fuzzy set λ = (1,1), have
recently had some health problems, and your physician has
advised you to reduce your consumption of cigarettes and al-
coholbyhalf.Theidealsituationforyourhealthis,ofcourse,
the point μ = (0,0), but it is possibly diﬃcult to achieve.
Cigarette smoking and alcohol drinking during ado-
lescence have been shown to be associated with a greater
possibility of concurrent and future substance-related disor-
Table 2: Number of nucleotides at the three base sites of a codon in
the coding sequence of Mycobacterium tuberculosis.
TCAG
First base 216051 409011 228244 470868
Second base 269638 416457 233472 404607
Third base 217803 458256 210892 437223
Table 3: Fractions of nucleotides at the three base sites of a codon
in the coding sequence of Mycobacterium tuberculosis.
TCAG
First base 0.1632 0.3089 0.1724 0.3556
Second base 0.2036 0.3145 0.1763 0.3056
Third base 0.1645 0.3461 0.1593 0.3302
ders(Lewinsohnetal[64];NelsonandWittchen[65]).Inor-
der to report patterns of drug use and to describe factors as-
sociated with substance use in adolescents, a cross-sectional
survey was carried out in a representative population sam-
ple of 2550 adolescents, aged 12 to 17 years, from Galicia
(an autonomous region located in the Northwest of Spain).
The original survey covered the use of alcohol, tobacco, il-
licit drugs, and other psychoactive substances. For tobacco
smoking and alcohol drinking, each subject of the popula-
tion sample was assigned a fuzzy degree of addiction (or risk
use) and mapped into the two-dimensional hypercube I2 by
an expert.
Several subjects occupy the same point in the two-
dimensional hypercube. For example Figure 2 represents the
number of subjects in the cross-sectional survey according
to the two fuzzy degrees of addiction. The reader can see that
thereare1278subjectscorresponding tothepoint(0,0),that
is, nonsmoker and teetotaler. Also 7 adolescents are at the
point (0.8,0.2). There are 121 subjects on the line of proba-
bility x1 + x2 = 1. Indeed (see Figure 2) ,2 3+1+1+2+2+
7+1+8 4= 121.
Most subjects were inside the hypercube but outside the
line of probability. This means that the vast majority of sub-
jects (2429/2550 ≈ 95.25%) are outside the line of probabil-
ity. This is in agreement with the fundamental limitation of
probability theory with respect to clinical science in general
[1] and agrees with its results (29/30 ≈ 96.66%).
We refer to [59] for details on the general theory of fuzzy
midpoints andtheirapplications. Ithasbeenusedrecentlyto
average biopolymers [66].
AN APPLICATION TO THE COMPARISON OF GENOMES
Whole genome sequence comparison is important in bioin-
formatics [44, 67].
T h ec o m p l e t eg e n o m es e q u e n c eo fMycobacterium tu-
berculosis H37Rv is available at http://www.ncbi.nlm.nih.gov
with accession number NC 000962.
The genome comprises 4411529 base pairs, contains
around 4000 genes, and has a very high guanine+cytosineA .T o r r e sa n dJ .J .N i e t o 5
Table 4: Number of nucleotides at the three base sites of a codon in
the coding sequence of Aquifex aeolicus.
TCAG
First base 82722 77800 157096 167050
Second base 159068 84092 168591 72917
Third base 103692 119016 147956 114004
Table 5: Fractions of nucleotides at the three base sites of a codon
in the coding sequence of Aquifex aeolicus.
TCAG
First base 0.1706 0.1605 0.3241 0.3446
Second base 0.3282 0.1735 0.3478 0.1504
Third base 0.2139 0.2455 0.3052 0.2352
content [68]. Computing [44] the number of the nucleotides
at the three base sites of a codon in the coding sequences
of M tuberculosis (Table 2), and then calculating the corre-
spondingfractions,wehavethefuzzysetoffrequenciesofthe
genome sequence of M tuberculosis (Table 3). This set can be
considered as a point in the hypercube I12. Indeed, the point
(0.1632,0.3089,0.1724,0.3556,0.2036,0.3145,
0.1763,0.3056,0.1645,0.3461,0.1593,0.3302) ∈ I12.
(6)
Aquifex aeolicus was one of the earliest diverging, and
is one of the most thermophilic, bacteria known [69]. It
can grow on hydrogen, oxygen, carbon dioxide, and min-
eral salts. The complex metabolic machinery needed for A
aeolicus to function as a chemolithoautotroph (an organism
which uses an inorganic carbon source for biosynthesis and
an inorganic chemical energy source) is encoded within a
genome that is only one-third the size of the Ec o l igenome.
The corresponding data for Aa e o l i c u swas obtained
from http://www.ncbi.nlm.nih.gov with accession number
NC 000918, and is presented in Tables 4 and 5,r e s p e c t i v e l y .
Thecompletegenomesequencehas1551335basepairs. The
fuzzy set of frequencies of the genome of Aa e o l i c u sis
(0.1706,0.1605,0.3241,0.3446,0.3282,0.1735,
0.3478,0.1504,0.2139,0.2455,0.3052,0.2352) ∈ I12.
(7)
Using the distance given in (5), it is possible to compute
the distance between these two fuzzy sets representing the
frequencies of the nucleotides of Aa e o l i c u sand Mt u b e r c u -
losis:
d(A aeolicus, M tuberculosis) =
2.2125
6.106
≈ 0.3623. (8)
In [44]wecalculatethediﬀerencebetween Mtuberculosis
and E coli K-12 obtaining
d(M tuberculosis, E coli) =
0.8506
3.4253
≈ 0.2483. (9)
Using the corresponding data for Ec o l i(see [44, Tables 3 and
4]), we get
d(A aeolicus, E coli) =
0.8514
5.0161
≈ 0.1697. (10)
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